Penumbra EBIT Margin 2014-2025 | PEN
Penumbra EBIT Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM EBIT | EBIT Margin |
2025-06-30 | $1.28B | $0.16B | 12.42% |
2025-03-31 | $1.24B | $0.04B | 2.98% |
2024-12-31 | $1.20B | $0.01B | 0.75% |
2024-09-30 | $1.16B | $0.00B | 0.09% |
2024-06-30 | $1.13B | $-0.02B | -1.85% |
2024-03-31 | $1.10B | $0.08B | 7.12% |
2023-12-31 | $1.06B | $0.07B | 6.99% |
2023-09-30 | $0.99B | $0.04B | 4.43% |
2023-06-30 | $0.94B | $0.04B | 3.84% |
2023-03-31 | $0.88B | $0.02B | 2.04% |
2022-12-31 | $0.85B | $0.01B | 0.71% |
2022-09-30 | $0.83B | $-0.04B | -4.70% |
2022-06-30 | $0.81B | $-0.04B | -4.34% |
2022-03-31 | $0.78B | $-0.03B | -3.20% |
2021-12-31 | $0.75B | $-0.01B | -1.07% |
2021-09-30 | $0.71B | $0.03B | 4.23% |
2021-06-30 | $0.67B | $0.00B | 0.15% |
2021-03-31 | $0.59B | $-0.03B | -4.56% |
2020-12-31 | $0.56B | $-0.04B | -6.96% |
2020-09-30 | $0.54B | $-0.03B | -4.83% |
2020-06-30 | $0.53B | $0.01B | 1.33% |
2020-03-31 | $0.56B | $0.04B | 6.83% |
2019-12-31 | $0.55B | $0.05B | 8.78% |
2019-09-30 | $0.52B | $0.04B | 8.41% |
2019-06-30 | $0.50B | $0.01B | 2.02% |
2019-03-31 | $0.47B | $0.01B | 1.27% |
2018-12-31 | $0.45B | $0.00B | -0.22% |
2018-09-30 | $0.42B | $0.00B | -0.95% |
2018-06-30 | $0.39B | $0.02B | 4.58% |
2018-03-31 | $0.36B | $0.01B | 2.20% |
2017-12-31 | $0.33B | $0.00B | 0.60% |
2017-09-30 | $0.31B | $0.00B | -0.96% |
2017-06-30 | $0.29B | $-0.01B | -1.70% |
2017-03-31 | $0.28B | $-0.01B | -1.80% |
2016-12-31 | $0.26B | $0.00B | -0.38% |
2016-09-30 | $0.24B | $0.00B | 0.82% |
2016-06-30 | $0.23B | $0.01B | 2.20% |
2016-03-31 | $0.20B | $0.00B | 0.98% |
2015-12-31 | $0.19B | $0.00B | 2.16% |
2015-06-30 | $0.11B | 0 | 0.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $9.359B | $1.195B |
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Intuitive Surgical (ISRG) | United States | $169.939B | 70.44 |
Thermo Fisher Scientific (TMO) | United States | $169.525B | 20.51 |
IDEXX Laboratories (IDXX) | United States | $49.938B | 51.97 |
Edwards Lifesciences (EW) | United States | $46.113B | 30.59 |
Alcon (ALC) | Switzerland | $41.492B | 28.04 |
IQVIA Holdings (IQV) | United States | $30.173B | 17.05 |
DexCom (DXCM) | United States | $29.961B | 44.94 |
Mettler-Toledo (MTD) | United States | $25.169B | 29.87 |
STERIS (STE) | Ireland | $21.761B | 23.19 |
Waters (WAT) | United States | $16.531B | 22.71 |
SONOVA HOLDING (SONVY) | Switzerland | $16.275B | 0.00 |
Hologic (HOLX) | United States | $14.878B | 16.12 |
Sysmex ADR (SSMXY) | Japan | $9.606B | 30.52 |
Masimo (MASI) | United States | $7.858B | 26.44 |
Globus Medical (GMED) | United States | $7.152B | 17.04 |
Glaukos (GKOS) | United States | $5.075B | 0.00 |
Teleflex (TFX) | United States | $4.953B | 7.99 |
TransMedics (TMDX) | United States | $4.050B | 61.55 |
Integer Holdings (ITGR) | United States | $3.691B | 18.42 |
LivaNova (LIVN) | United Kingdom | $2.582B | 14.80 |
PROCEPT BioRobotics (PRCT) | United States | $2.528B | 0.00 |
Alphatec Holdings (ATEC) | United States | $2.249B | 0.00 |
Nihon Kohden (NHNKY) | Japan | $1.948B | 23.26 |
Veracyte (VCYT) | United States | $1.877B | 26.05 |
Elekta AB (EKTAY) | Sweden | $1.825B | 16.41 |
Artivion (AORT) | United States | $1.378B | 129.08 |
Pulse Biosciences (PLSE) | United States | $1.032B | 0.00 |
OPKO Health (OPK) | United States | $1.008B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $0.964B | 5.52 |
Tandem Diabetes Care (TNDM) | United States | $0.958B | 0.00 |
IRadimed (IRMD) | United States | $0.894B | 43.41 |
SiBone (SIBN) | United States | $0.699B | 0.00 |
Beta Bionics (BBNX) | United States | $0.661B | 0.00 |
AxoGen (AXGN) | United States | $0.633B | 0.00 |
Semler Scientific (SMLR) | United States | $0.528B | 4.24 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.491B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.479B | 8.47 |
OrthoPediatrics (KIDS) | United States | $0.435B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.414B | 0.00 |
Delcath Systems (DCTH) | United States | $0.371B | 88.67 |
Treace Medical Concepts (TMCI) | United States | $0.344B | 0.00 |
AngioDynamics (ANGO) | United States | $0.341B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.341B | 8.67 |
RxSight (RXST) | United States | $0.307B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.302B | 0.00 |
NeuroPace (NPCE) | United States | $0.292B | 0.00 |
Neuronetics (STIM) | United States | $0.281B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.268B | 18.49 |
Alpha Tau Medical (DRTS) | Israel | $0.265B | 0.00 |
908 Devices (MASS) | United States | $0.234B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.196B | 0.00 |
Sight Sciences (SGHT) | United States | $0.190B | 0.00 |
CVRx (CVRX) | United States | $0.185B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.173B | 0.00 |
Inogen (INGN) | United States | $0.169B | 0.00 |
LENSAR (LNSR) | United States | $0.154B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.149B | 0.00 |
Accuray (ARAY) | United States | $0.148B | 0.00 |
Anteris Technologies Global (AVR) | Australia | $0.137B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.119B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.107B | 0.00 |
Microbot Medical (MBOT) | United States | $0.104B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.102B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.096B | 0.00 |
Hyperfine (HYPR) | United States | $0.091B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.088B | 53.30 |
InspireMD (NSPR) | United States | $0.077B | 0.00 |
Spectral AI (MDAI) | United States | $0.062B | 0.00 |
Positron (POSC) | United States | $0.055B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.053B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.047B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
Precision Optics (POCI) | United States | $0.035B | 0.00 |
Envoy Medical (COCH) | United States | $0.032B | 0.00 |
DarioHealth (DRIO) | United States | $0.024B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
NexGel (NXGL) | United States | $0.019B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.014B | 0.00 | |
Tenon Medical (TNON) | United States | $0.011B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
PAVmed (PAVM) | United States | $0.008B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
Venus Concept (VERO) | Canada | $0.003B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Nuwellis (NUWE) | United States | $0.001B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 12.44 |